South Korea: Plasma Donation by Shincheonji Church Facilitates Development of the Vaccine for COVID-19

Advertisements
Advertisements
Advertisements
Advertisements
Advertisements
Advertisements

To develop treatment and vaccine for COVID-19, research and development of the convalescent plasma treatment is underway by the National Institute of Health under the Ministry of Health and Welfare in cooperation with Green Cross(GC) Pharma, a biotechnology company in South Korea.

 

In this progress, according to the report from the Korea Centers for Disease Control and Prevention(KCDC), 562 recovered members from Shincheonji Church, a minor sect in South Korea, registered to donate plasma and 409 completed donations in July through the cooperation between KCDC and Shincheonji Church.

Advertisements

 

It was possible as early this year, around 5,000 confirmed cases were found in Shincheonji Church members with most infections from the city of Daegu, while most of them recovered from the virus with 11 deaths.

 

Major challenges of researching the effectiveness and the development of convalescent plasma treatment come from limited supply from donors who must be recovered from the virus.

 

It is said that, for this reason, the members of Shincheonji Church decided to donate their blood plasma to accelerate development of convalescent plasma treatment, bearing physical demanding and discrimination toward the church.

Advertisements

3 thoughts on “South Korea: Plasma Donation by Shincheonji Church Facilitates Development of the Vaccine for COVID-19

  1. It is sad that they were so horribly affected by this virus. But thankfully they are so generous with their help in finding a cure.

Leave a Reply

Your email address will not be published. Required fields are marked *